EP0511726B1 - Dispositif pour tenir des comprimés en emballage sans coquille - Google Patents

Dispositif pour tenir des comprimés en emballage sans coquille Download PDF

Info

Publication number
EP0511726B1
EP0511726B1 EP92250101A EP92250101A EP0511726B1 EP 0511726 B1 EP0511726 B1 EP 0511726B1 EP 92250101 A EP92250101 A EP 92250101A EP 92250101 A EP92250101 A EP 92250101A EP 0511726 B1 EP0511726 B1 EP 0511726B1
Authority
EP
European Patent Office
Prior art keywords
tablets
blister pack
deck
cover
assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP92250101A
Other languages
German (de)
English (en)
Other versions
EP0511726A2 (fr
EP0511726A3 (en
Inventor
Stephan Charles Allendorf
Thomas Mitchell Dair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Berlex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Laboratories Inc filed Critical Berlex Laboratories Inc
Publication of EP0511726A2 publication Critical patent/EP0511726A2/fr
Publication of EP0511726A3 publication Critical patent/EP0511726A3/en
Application granted granted Critical
Publication of EP0511726B1 publication Critical patent/EP0511726B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers

Definitions

  • the instant invention relates to an assembly for tablets, and more particularly, the instant invention relates to an assembly for retaining, concealing and dispensing tablets arrayed in blister packs and used for purposes such as birth control or hormone replacement therapy (HRT).
  • HRT hormone replacement therapy
  • birth control or HRT tablets generally requires that the tablets be taken one at a time in a preselected order on a daily basis.
  • the tablets are dispensed in accordance with either a 21-day cycle or a 28-day cycle regime. It has been found that utilizing blister packs arranged in seven columns, one for each day, and either three rows or four rows to make up the 21-day or 28-day cycle, provides a satisfactory approach.
  • U.S. Patent 4,817,819 is exemplary of an approach to packaging birth control tablets wherein the tablets are mounted on a sleeve which is retained in a tray; however, this approach requires the separate molding and assembly of two parts. Trays which have complex and extensive surface contact with the sleeves or covers in which they are received can upon occasion become jammed since debris can collect in convoluted surfaces.
  • DE-U-88 14 793 discloses a blister pack retained on a deck by a cover with a window therethrough; however, there is no structure for always correctly positioning the blister pack with respect to the deck and cover and no daily calendar is provided for identifying the correct starting date.
  • the instant invention contemplates an assembly for containing tablets, such as birth control tablets, in an array
  • the assembly comprises a blister pack containing a plurality of tablets disposed in an area of the blister pack and configured in a selected array and a container comprising a deck and cover.
  • the deck of the container includes a flat surface with a plurality of compartments therethrough, the compartments being arranged to correspond to the selected array of tablets in the blister pack.
  • the cover includes a rim portion of an area at least as large as the area of the blister pack and a window portion of an area less than the area of the blister pack and larger than the area of the selected array.
  • the cover is secured to the deck with the blister disposed therebetween, wherein the tablets and blister pack are visible and accessible through the window of the cover and the tablets are dispensable through the openings in the deck by pressing on the tablets through the window.
  • the cover includes a pointer proximate the window which cooperates with a locating notch on the blister pack to properly position the blister back within the container while indicating to the user which tablet in the array should be taken first.
  • a lockable cylinder with a day calendar thereon and in accordance with another embodiment a lockable loop with a day calendar thereon is provided.
  • the container of the assembly is unitary with the deck and cover being formed of one piece.
  • the assembly further includes a front lid and a back lid, the front lid being hinged to the cover and the back lid being hinged to the deck.
  • a latch is provided for latching the front and back lids to one another sandwiching the blister pack, cover and deck between the lids.
  • blister packs designated generally by the numerals 50a-50k, each of which have twenty-eight compartments 52 therein for receiving tablets, such as birth control or HRT tablets 53, which are taken by a consumer sequentially at a rate of one tablet per day.
  • tablets such as birth control or HRT tablets 53
  • indicators in the form of arrows 54 between each compartment 52 in a row and arrows 56 connecting the end of one row to the beginning of the next row are provided.
  • the rows of compartments 52 contain seven tablet compartments.
  • each tablet compartment 52 is numbered while, in Figures 3, 4, 6 and 7, no numbers are used and, in Figures 9 and 10, letters are used.
  • Each of the blister packs 50 includes a triangular notch 58 adjacent one edge 59a thereof so as to properly locate the blister pack in its respective container, the opposite edge 59b being alignable in the container for retaining the blister pack.
  • Graphics on the blister packs 50a-50k differ in appearance but all have the function of directing the user to sequentially consume the birth control or HRT tablets 53 in the right order. Without proper instruction, the consumer could possibly not follow the correct order by just selecting any tablet or perhaps taking tablets sequentially from the columns, i.e., vertically with respect to Figures 1-10, instead of horizontally. In order to be effective, it is important that the tablets 53 be consumed in the correct sequence.
  • the last seven compartments may either be empty or contain non-active tablets.
  • Figures 11-17 disclose a first embodiment of the invention wherein a container, designated generally by the numeral 60 has first, second, third and fourth panels 62, 64, 66 and 68, respectively.
  • panel 62 is joined to panel 64 via a living hinge 70;
  • panel 64 is joined to panel 66 via a living hinge 72;
  • panel 66 is joined to panel 68 via a living hinge 74.
  • Figures 11 and 12 are front and rear views, respectively, showing the container 60 closed with the panels 62-68 folded upon one another accordion fashion in the manner of Figure 17 to collapse as is illustrated in Figure 13.
  • the first panel 62 has an array of concave depressions 76 therein when viewed from the inside as in Figures 15 and 16 which appear as convex domes 78 on the outside surface thereof as in Figures 11, 13, 14 and 17.
  • the front cover formed by the first panel 62 has a lip 80 projecting therefrom which has a hooked end 82 adapted to snap over an edge 84 ( Figure 15) on the fourth panel 68.
  • the fourth panel 68 has a lip 86 with a hook 88 adapted to snap over an edge 90 of the first panel 62 so as to further hold the panels 62 and 68 superimposed with the second and third panels 64 and 66 sandwiched or folded therebetween.
  • a selected one of the blister packs 50 of Figures 1-10 is sandwiched between the second and third panels 64 and 66, respectively, with the tablets 53 facing through a window 92 defined by a rim 93 which comprises the second panel 64.
  • the third panel 66 forms a deck for supporting the blister pack 50 and has an array of twenty-eight openings 94 corresponding to the compartments 52 in the blister pack which hold the birth control tablets 53. Since the tablets 53 are exposed through the window 92 and the blister pack 50 is retained behind the back surface of the panel 64, the tablets may be popped out by pressing the tablets from the front side of the blister pack to pop the tablets through openings 94 in the third panel 66 which forms the deck for supporting the blister pack.
  • the second panel 64 has a V-shaped area 96 which is raised in the front view of Figures 15 and 16. Preferably, the word "START" is printed on the raised surface of the indicator 96.
  • While the third panel 66 has a raised indicator portion 98 which corresponds in shape to the recessed indicator portion 96 and registers with the notch 58 at the edge 59a of pack 50.
  • a lip 100 projecting from the back surface of the panel 64 as is shown in Figure 14 engages the edge 59b of the blister pack 50 mounted between the panels 66 and 64 so as to cooperate with the raised indicator 98 to hold the blister pack in place.
  • a slot 102 is placed in the second panel 64 and a strip 104, preferably a continuous loop 105 (Fig. 39), with the days of the week is placed in a recessed area 106 in the fourth panel 68 so as to be visible through the slot 102 when the container 60 is folded accordion fashion so as to close as is shown in Figures 13 and 17.
  • the continuous loop 105 has thirteen or more days thereon so that the starting day can be easily selected by the patient.
  • a locking detent 107 locks into recesses 108 in the loop 105 to prevent the loop from being moved after a starting day has been selected.
  • Container 60 is used as is shown in Figure 16 wherein when the panel 62 is pivoted from its Figure 12 to its Figure 16 position the tablets 53 are exposed through the window 92 for dispensing from the blister pack 50. As the tablets 53 are sequentially pressed, they rupture the back surface of the blister pack 50 and pass through the openings 94 in the third panel 66 which is exposed by rotating the fourth panel 68 which forms the rear cover of container 60 to an open position.
  • FIG. 11-17 provides a birth control container 60 which conceals the nature of the tablets 53 being dispensed by covering both the front and back side of the blister pack 50. Moreover, the container 60 is fabricated as a unitary, one-piece structure which is folded in a manner readily apparent to the user to perform its function of containing and concealing the blister pack 50.
  • the second embodiment of the container designated generally by the numeral 60a, is a four-panel container similar to the four-panel container of Figures 11-17, with the exception that the first or front panel 62a has planar inside and outside surfaces 110 and 112, respectively, instead of having the convex bumps 78 appearing on the outer surface 110 as is the case in the container 60 of Figures 11-17.
  • This is accomplished by providing the first panel 62a, which is the front cover, with a relatively wide pair of side edge flanges 114 (Fig. 20) so that when the cover is closed, as in Figure 20, the tablets 53 are concealed behind the side flanges 114.
  • the remainder of the container has a structural configuration substantially identical to that of the first embodiment of Figures 11-17.
  • a container, designated generally by numeral 120 comprises only two panels, front panel 122 and a rear panel 124.
  • first and fourth panels 62 and 68 are dispensed with so that the tablets 53 are always visible.
  • the tablets 53 are individually exposed through the openings 126 in the rear panel 124.
  • the blister pack 50 is sandwiched between the front cover 122 and the rear cover 124 with the front cover having a lip 126 which latches over the edge 128 of the rear cover and the rear cover having a lip 130 which latches over the edge 132 of the front cover.
  • the fourth embodiment of the invention has a structure substantially identical to the third embodiment; however, in the fourth embodiment, the front panel 122a and rear panel 124a of container 120 are of transparent plastic rather than opaque plastic.
  • the indicator 96 is configured by having the word "START" placed on the raised triangular area 96 on front panel 122a (see Figure 30).
  • the raised triangular area 134 is opaque so that it is visible through the corresponding transparent raised triangular area 136 of the front cover 122a.
  • the blister pack 50 is opaque so the raised area 134, which is preferably of a contrasting color to the blister pack, is highlighted to emphasize where the dosage starts by pointing to the "first tablet" 53 in the array of tablets.
  • the fifth embodiment of the tablet container is essentially similar to the third and fourth embodiments in which the blister pack 50 is retained between a front cover 122b and a rear cover 124b; however, in the fifth embodiment, a cylindrical calendar retainer 141 is disposed in proximity with the hinge 72b which connects the front cover 122b to the rear cover 124b. Disposed in the circular calendar retainer 141 is a cylindrical calendar, designated generally by the numeral 142, which has seven daily calendars 144 disposed around and extending axially along its surface. Each daily calendar 144 starts with a new day and can be selectively dialed into registration with a window 146 by rotating a knurled knob 148 on the end of the cylinder 142. Means are provided to fix the cylinder 142 in place so that it can not be readily rotated after being set for one cycle.
  • calendar retainer 141 is formed by a pair of cooperating cylinder halves 150 and 152 formed in the front and rear covers 122b and 124b, respectively.
  • the cylindrical calendar 142 is retained in the thus formed cylindrical calendar retainer 140.
  • the cylinder halves 150 and 152 each have semi-annular shoulder 154 and 156, respectively, which close around a reduced diameter portion 158 (Fig. 31) of the cylindrical calendar 142.
  • the tablet container 140 is substantially similar to the tablet container 120, with similar reference numerals identifying substantially similar structure.
  • the calendar cylinder 142 or the loop 105 has the days Saturday 143 and Sunday 145 highlighted or shaded in a color different from the other days to assist the user in coordinating her cycle with her weekly schedule.
  • the blister pack container 120, 120a and 140 of Figures 24 - 35 each have blister packs 50 which are readily visible.
  • the containers 120, 120a and 140 may be carried in a plastic retainer 162 resembling a wallet or business card holder which has a pocket 164 for retaining the container formed in a back flap 166 of the retainer.
  • the container 120, 120a or 140 is then concealed by a front flap 168 hinged to the back flap 166.
  • the plastic retainer 162 may, of course, also be used to carry the four panel tablet containers 60 and 60a.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)

Claims (10)

  1. Assemblage (60, 60a, 120, 120a, 140) destiné à contenir des comprimés, tels que des pilules contraceptives ou des comprimés d'hormonothérapie substitutive, disposés suivant un certain agencement, dans lequel l'assemblage comprend : un emballage pelliculé (50) d'une surface prédéterminée contenant une pluralité de comprimés disposés dans une surface à comprimés de l'emballage pelliculé, et agencés suivant un ordre choisi, un étui comprenant un plateau (66, 124, 124a, 124b) et une couverture (62,62a, 122, 122a, 122b) reliée au plateau par charnière, le plateau comprenant une surface plate avec une pluralité d'ouvertures (44) au travers de celle-ci, les ouvertures étant disposées de façon à correspondre à l'agencement choisi des comprimés dans l'emballage pelliculé, la couverture comportant une partie de rebord (93) d'une surface supérieure à la surface à comprimés de l'emballage pelliculé, et une partie de fenêtre ouverte (92) d'une surface inférieure à la surface prédéterminée de l'emballage pelliculé, et supérieure à la surface à comprimés, dans lequel l'emballage pelliculé est disposé entre le plateau et la couverture, et les comprimés peuvent être distribués au travers des ouvertures du plateau en appuyant sur les comprimés au travers de la fenêtre, caractérisé par :
    un calendrier journalier (104, 142) associé à l'assemblage et pouvant être aligné avec la suite de comprimés (53), le calendrier journalier (104, 142) pouvant être déplacé afin de positionner un jour de début de prise déterminé en correspondance avec un premier comprimé (1) de la suite de comprimés (53), et en ce que le couvercle (93, 120) comprend un repère (96) à proximité de la fenêtre ouverte (92), l'emballage pelliculé (50) comprenant une encoche de positionnement (58) à proximité de son bord et à proximité du premier comprimé, dans lequel le repère (96) est logé dans l'encoche (58) afin de positionner correctement l'emballage pelliculé (50) à l'intérieur de la fenêtre ouverte (92) et d'indiquer le premier comprimé (1) à prendre.
  2. Assemblage selon la revendication 1, dans lequel la charnière (72) est solidaire de la couverture (120) et du plateau (124) et s'étend le long d'un bord du plateau (124) et d'un bord adjacent de la couverture (122), les bords opposés de la couverture (120) et du plateau (124) étant des bords libres.
  3. Assemblage selon la revendication 2, comprenant en outre des moyens (128, 130) le long des bords libres de la couverture (120) et du plateau (124) destinés à verrouiller la couverture et le plateau l'un à l'autre.
  4. Assemblage selon la revendication 1, comprenant en outre un couvercle avant (62) et un couvercle arrière (68), le couvercle avant (62) étant relié par charnière à la couverture (93) et le couvercle arrière (68) étant relié par charnière au plateau (66), et des moyens de verrouillage (80 et 86) sur le couvercle avant (62) et le couvercle arrière (68) permettant de verrouiller les couvercles (62, 68) l'un à l'autre, et conçus pour retenir l'emballage pelliculé (50), la couverture (93) et le plateau (66) pris en sandwich entre les couvercles (62 et 68).
  5. Assemblage selon la revendication 1, dans lequel les comprimés (53) sont disposés en rangées de sept comprimés et en colonnes de quatre comprimés, et
       dans lequel la couverture (93) comprend le calendrier journalier (104, 142) sur celle-ci à proximité de chaque colonne, indiquant le jour de la semaine.
  6. Assemblage selon la revendication 5, dans lequel l'emballage pelliculé (50) comprend des repères (56) sur celui-ci indiquant l'ordre dans lequel les comprimés doivent être pris.
  7. Assemblage selon la revendication 6, dans lequel le moyen de calendrier journalier est un calendrier cylindrique (142) avec sept listes axiales de jours, à l'aide duquel on choisit un jour de début de prise en faisant tourner le calendrier.
  8. Assemblage selon la revendication 7, comprenant en outre des moyens destinés à verrouiller le calendrier cylindrique dans une position choisie.
  9. Assemblage selon la revendication 1, dans lequel le moyen de calendrier (104) est une boucle (105) positionnée sur le plateau (66), la boucle (105) pouvant être déplacée par rapport au plateau (66) afin de positionner un jour choisi à proximité d'un premier comprimé (1) de la suite de comprimés.
  10. Assemblage selon la revendication 1, comprenant en outre un verrou (107) destiné à verrouiller la boucle dans une position choisie.
EP92250101A 1991-04-29 1992-04-29 Dispositif pour tenir des comprimés en emballage sans coquille Expired - Lifetime EP0511726B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69312791A 1991-04-29 1991-04-29
US693127 1991-04-29

Publications (3)

Publication Number Publication Date
EP0511726A2 EP0511726A2 (fr) 1992-11-04
EP0511726A3 EP0511726A3 (en) 1992-12-23
EP0511726B1 true EP0511726B1 (fr) 1997-07-16

Family

ID=24783423

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92250101A Expired - Lifetime EP0511726B1 (fr) 1991-04-29 1992-04-29 Dispositif pour tenir des comprimés en emballage sans coquille

Country Status (7)

Country Link
EP (1) EP0511726B1 (fr)
AT (1) ATE155340T1 (fr)
CA (1) CA2067611A1 (fr)
DE (1) DE69220842T2 (fr)
DK (1) DK0511726T3 (fr)
ES (1) ES2107499T3 (fr)
GR (1) GR3024935T3 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10217929A1 (de) * 2002-04-22 2003-11-06 Sixp Ag Vorrichtung zur Ausgabe von Tabletten
DE102007037374A1 (de) 2007-08-06 2009-02-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zum Aufbewahren und Bereitstellen von Arzneimittel-Wafern
DE102009008028A1 (de) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung eines Taschenstapels von zur Aufbewahrung und Bereitstellung von Arzneimittelwafern dienenden Arzneimitteltaschen
WO2010089090A1 (fr) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Dispositif et son utilisation pour la conservation et la mise à disposition de médicaments sous forme stratifiée
WO2010089091A1 (fr) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Procédé pour produire un empilement de pochettes servant à conserver et à mettre à disposition des médicaments sous forme stratifiée, modèle de pochette pour produire ledit empilement et utilisation dudit modèle
DE102009008026A1 (de) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung eines Stapels von Arzneimitteltaschen, Arzneimitteltaschenvorlage zur Herstellung des Stapels sowie Verwendung der Arzneimitteltaschenvorlage

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE223243T1 (de) 1996-04-25 2002-09-15 Astrazeneca Ab Inhalator
US20010044427A1 (en) 1999-12-20 2001-11-22 Sidney Mazel Pharmaceutical kit
US6978894B2 (en) 1999-12-20 2005-12-27 Merck & Co., Inc. Blister package for pharmaceutical treatment card
US20040188316A1 (en) 2003-03-26 2004-09-30 The Procter & Gamble Company Kit for pharmaceutical use
US8752704B2 (en) 2010-12-17 2014-06-17 The Procter & Gamble Company Blister cards promoting intuitive dosing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1883776U (de) * 1963-07-31 1963-11-28 Schering Ag Tablettendurchdruckpackung.
US3530818A (en) * 1968-08-19 1970-09-29 Lilly Co Eli Pill dispenser with indicating means
US3579883A (en) * 1969-02-24 1971-05-25 Lilly Co Eli Pill dispenser with indicating means
US3630171A (en) * 1969-09-29 1971-12-28 Ortho Pharma Corp Tablet-dispensing device
NL8402622A (nl) * 1984-08-29 1986-03-17 Robert Maas Houder voor een pillenstrip.
DE8814793U1 (de) * 1988-11-28 1989-02-23 Lobermeier, Hans, 6050 Offenbach Verpackung für kleindimensionierte Waren, wie Tabletten, Pillen, Bonbons u.dgl.
US5082113A (en) * 1990-05-02 1992-01-21 Romick Jerome M Unit-dose medication handling and dispensing system with signalling tabs and flap

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10217929A1 (de) * 2002-04-22 2003-11-06 Sixp Ag Vorrichtung zur Ausgabe von Tabletten
DE102007037374A1 (de) 2007-08-06 2009-02-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zum Aufbewahren und Bereitstellen von Arzneimittel-Wafern
DE102009008028A1 (de) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung eines Taschenstapels von zur Aufbewahrung und Bereitstellung von Arzneimittelwafern dienenden Arzneimitteltaschen
WO2010089090A1 (fr) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Dispositif et son utilisation pour la conservation et la mise à disposition de médicaments sous forme stratifiée
WO2010089091A1 (fr) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Procédé pour produire un empilement de pochettes servant à conserver et à mettre à disposition des médicaments sous forme stratifiée, modèle de pochette pour produire ledit empilement et utilisation dudit modèle
DE102009008027A1 (de) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Vorrichtung und Verwendung zur Aufbewahrung und Bereitstellung von Arzneimittelwafern
DE102009008026A1 (de) 2009-02-06 2010-08-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung eines Stapels von Arzneimitteltaschen, Arzneimitteltaschenvorlage zur Herstellung des Stapels sowie Verwendung der Arzneimitteltaschenvorlage

Also Published As

Publication number Publication date
DK0511726T3 (da) 1998-02-09
DE69220842T2 (de) 1998-01-22
EP0511726A2 (fr) 1992-11-04
EP0511726A3 (en) 1992-12-23
GR3024935T3 (en) 1998-01-30
ATE155340T1 (de) 1997-08-15
DE69220842D1 (de) 1997-08-21
CA2067611A1 (fr) 1992-10-30
ES2107499T3 (es) 1997-12-01

Similar Documents

Publication Publication Date Title
US5265728A (en) Arrangement for retaining blister pack tablets
US4693371A (en) Medication dispenser and container
US4817819A (en) Container for tablets
EP0511726B1 (fr) Dispositif pour tenir des comprimés en emballage sans coquille
US7128213B2 (en) Convertible pill container
US6041932A (en) Vitamin organizing, storing and dispensing system
US6662081B1 (en) Medication regimen container and system
US3393795A (en) Dispensing container
US4905388A (en) Organizer and reminder device for pills, medicines and the like
US8936157B1 (en) Indexing multi-compartment container-cap assembly
US4890741A (en) Capsule package
US20140251863A1 (en) Push button pill container with register and methods
US3381808A (en) Dispensing package
US4573580A (en) Unit dose medication dispenser
US20140251861A1 (en) Pill container with register and push button lids and methods
US4127190A (en) Dispenser for dispensing pills or tablets in a predetermined order
CA2613857C (fr) Etui pour recevoir un emballage de medicament et utilisation associee
US20140251862A1 (en) Pill containers with registers and methods
US3738480A (en) Medication container
US3817372A (en) Pocket pill box
AU7507098A (en) Dosage regimen container
US3570707A (en) Tablet dispenser
US5105949A (en) Medicine and record holder
EP0232674B1 (fr) Récipient pour comprimés
WO2005023672A1 (fr) Distributeur

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920521

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19950322

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE

REF Corresponds to:

Ref document number: 155340

Country of ref document: AT

Date of ref document: 19970815

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69220842

Country of ref document: DE

Date of ref document: 19970821

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: E. BLUM & CO. PATENTANWAELTE

ITF It: translation for a ep patent filed

Owner name: STUDIO CONS. BREVETTUALE S.R.L.

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2107499

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3024935

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 19971013

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060430

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20070308

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20070315

Year of fee payment: 16

Ref country code: DK

Payment date: 20070315

Year of fee payment: 16

Ref country code: NL

Payment date: 20070315

Year of fee payment: 16

Ref country code: GB

Payment date: 20070315

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20070319

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20070321

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20070326

Year of fee payment: 16

Ref country code: DE

Payment date: 20070326

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20070330

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20070410

Year of fee payment: 16

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: BERLEX LABORATORIES, INC.

Free format text: BERLEX LABORATORIES, INC.#110 EAST HANOVER AVENUE#CEDAR KNOLLS, NJ 07927-2094 (US) -TRANSFER TO- BERLEX LABORATORIES, INC.#110 EAST HANOVER AVENUE#CEDAR KNOLLS, NJ 07927-2094 (US)

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20070323

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20070312

Year of fee payment: 16

BERE Be: lapsed

Owner name: *BERLEX LABORATORIES INC.

Effective date: 20080430

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20081029

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

EUG Se: european patent has lapsed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20080429

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20081101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081101

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081101

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081029

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20081231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20080430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081104

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430